These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15210158)

  • 21. Cytotoxic alpha-bromoacrylic derivatives of distamycin analogues modified at the amidino moiety.
    Cozzi P; Beria I; Caldarelli M; Geroni C; Mongelli N; Pennella G
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1273-6. PubMed ID: 10866398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent antitumor 9-anilinoacridines and acridines bearing an alkylating N-mustard residue on the acridine chromophore: synthesis and biological activity.
    Su TL; Lin YW; Chou TC; Zhang X; Bacherikov VA; Chen CH; Liu LF; Tsai TJ
    J Med Chem; 2006 Jun; 49(12):3710-8. PubMed ID: 16759114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and preliminary cytotoxicity of nitrogen mustard derivatives of distamycin A.
    Wang Y; Wright SC; Larrick JW
    Bioorg Med Chem Lett; 2003 Feb; 13(3):459-61. PubMed ID: 12565950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells.
    Xia Y; Fan CD; Zhao BX; Zhao J; Shin DS; Miao JY
    Eur J Med Chem; 2008 Nov; 43(11):2347-53. PubMed ID: 18313806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA sequence-recognizing properties of minor groove alkylating agents. Effects of the replacement of N-methylpyrrole by an N-methylimidazole on tallimustine and its own homologue.
    Baraldi PG; Romagnoli R; Spalluto G; Cozzi P; Mongelli N; Bianchi N; Gambari R
    Arzneimittelforschung; 2000 Mar; 50(3):309-15. PubMed ID: 10758785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
    El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
    Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
    Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
    J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The discovery of a new potential anticancer drug: a case history.
    Cozzi P
    Farmaco; 2003 Mar; 58(3):213-20. PubMed ID: 12620417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
    Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
    Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin.
    Broggini M; Coley HM; Mongelli N; Pesenti E; Wyatt MD; Hartley JA; D'Incalci M
    Nucleic Acids Res; 1995 Jan; 23(1):81-7. PubMed ID: 7870593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
    Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
    Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinatorial identification of a novel consensus sequence for the covalent DNA-binding polyamide tallimustine.
    Sunavala-Dossabhoy G; Van Dyke MW
    Biochemistry; 2005 Feb; 44(7):2510-22. PubMed ID: 15709763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitors.
    Lin R; Chiu G; Yu Y; Connolly PJ; Li S; Lu Y; Adams M; Fuentes-Pesquera AR; Emanuel SL; Greenberger LM
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4557-61. PubMed ID: 17574416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hybrid molecules between distamycin A and active moieties of antitumor agents.
    Baraldi PG; Preti D; Fruttarolo F; Tabrizi MA; Romagnoli R
    Bioorg Med Chem; 2007 Jan; 15(1):17-35. PubMed ID: 17081759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological activity of alpha-bromoacryloyl lexitropsin conjugates.
    Romagnoli R; Baraldi PG; Iaconinoto MA; Carrion MD; Tabrizi MA; Gambari R; Borgatti M; Heilmann J
    Eur J Med Chem; 2005 Nov; 40(11):1123-8. PubMed ID: 16006014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent outcome in the field of distamycin-derived minor groove binders.
    Cozzi P
    Farmaco; 2000 Mar; 55(3):168-73. PubMed ID: 10919073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, solvolytic stability and cytotoxicity of a modified derivative of CPzI, a pyrazole analog of the alkylation subunit of the antitumor agent CC-1065: effect of the nitrogen substitution on the functional reactivity.
    Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Zaid AN; Capolongo L; Cozzi P; Geroni C; Mongelli N
    Farmaco; 1997 Dec; 52(12):717-23. PubMed ID: 9648275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
    Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
    J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
    Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA
    J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and preliminary biological evaluation of novel ethyl 1-(2'-hydroxy-3'-aroxypropyl)-3-aryl-1H-pyrazole-5-carboxylate.
    Wei F; Zhao BX; Huang B; Zhang L; Sun CH; Dong WL; Shin DS; Miao JY
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6342-7. PubMed ID: 17000107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.